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The real time dynamics of vanilloid-induced cytotox-
icity and the specific deletion of nociceptive neurons
expressing the wild-type vanilloid receptor (VR1) were
investigated. VR1 was C-terminally tagged with either
the 27-kDa enhanced green fluorescent protein (eGFP)
or a 12-amino acid e-epitope. Upon exposure to resinif-
eratoxin, VR1eGFP- or VR1e-expressing cells exhibited
pharmacological responses similar to those of cells ex-
pressing the untagged VR1. Within seconds of vanilloid
exposure, the intracellular free calcium ([Ca21]i) was
elevated in cells expressing VR1. A functional pool of
VR1 also was localized to the endoplasmic reticulum
that, in the absence of extracellular calcium, also was
capable of releasing calcium upon agonist treatment.
Confocal imaging disclosed that resiniferatoxin treat-
ment induced vesiculation of the mitochondria and the
endoplasmic reticulum (;1 min), nuclear membrane dis-
ruption (5–10 min), and cell lysis (1–2 h). Nociceptive
primary sensory neurons endogenously express VR1,
and resiniferatoxin treatment induced a sudden in-
crease in [Ca21]i and mitochondrial disruption which
was cell-selective, as glia and non-VR1-expressing neu-
rons were unaffected. Early hallmarks of cytotoxicity
were followed by specific deletion of VR1-expressing
cells. These data demonstrate that vanilloids disrupt
vital organelles within the cell body and, if administered
to sensory ganglia, may be employed to rapidly and se-
lectively delete nociceptive neurons.
Capsaicin (CAP),1 a well characterized membrane-perme-
able vanilloid agonist, has potent stimulatory actions on noci-
ceptive neurons and causes loss of unmyelinated “C”-type sen-
sory afferents when administered to newborn animals (1, 2).
Similarly, resiniferatoxin (RTX), an ultrapotent capsaicin an-
alogue, can deplete [3H]RTX-binding sites from the brain stem,
the sensory ganglia (dorsal root and trigeminal), and the spinal
cord with a mechanism that has not been fully elucidated (3, 4).
Both systemic and epidural administration of RTX to adult rats
produce analgesia to subsequent noxious thermal stimulation
(5). Depending on concentration, duration of exposure, and
route of administration, vanilloid ligands may either desensi-
tize the nociceptive primary afferent nerve ending or com-
pletely delete the neuron itself (6–8). Previous studies inves-
tigating the processes of desensitization and cell loss mainly
examined whole animals or primary cultures of dorsal root
ganglia, where nociceptive neuronal cell bodies are located. The
cloning of the first isotype of the vanilloid receptor (VR1) pro-
vides a means to investigate more fully the molecular and cell
biological mechanisms of pain signal transduction and the pro-
cesses underlying susceptibility of VR1-expressing cells to im-
pairment upon exposure to vanilloid agonists (9). The VR1 has
been characterized as a Ca21 ionophore (9, 10); thus, it also
provides a very specific molecule with which to investigate the
role of ligand-activated transmembrane calcium fluxes in cel-
lular toxicity.
The VR1 exhibits homology to Ca21 store-dependent TRP
channels. In contrast to TRPs, which regulate intracellular
calcium stores, VR1 confers two pivotal sensory functions. VR1
transduces chemical (vanilloids and pH) and physical (heat)
stimuli at the molecular level, generating action potentials in
nociceptive nerve endings, and ultimately leading to sensations
of heat, thermal pain, and inflammatory pain (10, 11). Loss of
moderately noxious heat and vanilloid-stimulated sensory
functions has been verified in animals lacking VR1 (11, 12).
VR1 mRNA is expressed with remarkable cell and tissue spec-
ificity in the DRG. Immunocytochemistry demonstrates VR1
throughout the peripheral endings, cell body, and presynaptic
terminals of small size dorsal root ganglion (DRG) neurons (10,
13). These sites coincide well with regional localization of
[3H]RTX binding (3, 4). The ability of CAP and RTX to displace
[3H]RTX binding in the spinal cord and DRG as well as simi-
larities in [3H]RTX binding studies with recombinantly ex-
pressed VR1 suggest that both vanilloids act on the same
receptors (14).
Previous studies with vanilloids have shown that vanilloid
administration can lead to cell type-specific membrane dam-
age. Long term exposure to vanilloids causes profound ultra-
structural changes in DRG neurons (15, 16). VR1-specific an-
tibodies have been used in intracellular localization by light
and electron microscopy, but the functional relationship of
these morphological observations to the observed cell damage
has not been explored (10, 13). Immunostaining of fixed cells
often limits detailed visual observation of rapid intracellular
processes. In the present paper, we used fluorescence confocal
microscopy and real time imaging of enhanced green fluores-
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cent protein (eGFP)-tagged VR1 (VR1eGFP) to examine simul-
taneously both the morphological and functional molecular pro-
cesses underlying the immediate effects of vanilloid exposure
on the perikarya of cells and neurons with high temporal and
spatial resolution. Biochemical functions in the plasma mem-
brane (membrane potential changes, calcium uptake, and
[3H]RTX binding) similar to wild-type VR1 were readily ob-
served with the chimeric VR1eGFP. In addition, another active
pool of VR1 was located at the endoplasmic reticulum (ER),
which also reacted within seconds to vanilloid treatment.
Exposure of VR1-expressing cells to vanilloids produced a
rapidly evolving cytotoxicity. This commenced with a rise in
[Ca21]i, which quickly surpassed the Ca
21 tolerance or seques-
tration capacity of the mitochondria. Subsequently, nuclear
envelope shrinkage and blebbing occurred, followed by cell
death. The effect of elevated [Ca21]i on vital organelles sug-
gests that targeted administration of vanilloid agents to the
cell body can rapidly compromise and then eliminate (within
hours) VR1-expressing nociceptive neurons. In fact, immuno-
blot analysis of protein extracts from primary DRG cultures
showed that treatment with any of several vanilloid agonists
eliminated cells expressing the VR1.
EXPERIMENTAL PROCEDURES
RT-PCR Cloning and Epitope Tagging—To obtain VR1-specific
mRNA, 100 DRGs were rapidly removed from 12 adult Harlan Sprague-
Dawley rats. Total RNA was isolated with the TRI REAGENT (Molec-
ular Research Center Inc., Cincinnati, OH). A fragment, comprising the
sequence between the XbaI and AflIII sites of rat VR1, was amplified
first by the Access RT-PCR system (Promega) and then cloned into the
BlueScript vector (Stratagene). The missing 59-sequence was added
likewise with the SacI and XbaI sites. At the 59 ends of the N- and
C-terminal fragments, the SacI and AflIII sites (underlined) were in-
corporated with forward primers AGATCTCGAGCTCAAATGGAACA-
ACGGGCTAGCTTAGACTC and CTGTATTCCACATGTCTGGAGCTG-
TTCAAGTTC, respectively. As reverse primers ACTGAGTCCCGGGC-
GCTGATGTCTGCAGGCT and CACACAGTCGACTTTCTCCCCTGG-
GACCATGGAATCCTT were used, in which the XbaI and SalI sites
were incorporated, respectively. The SacI-AflIII and the RT-PCR-
generated AflIII-SalI fragments were triple-ligated into a SacI and SalI
cut pEGFP-N3 vector (CLONTECH). The immediate early promoter of
the cytomegalovirus in the pEGFP-N3 vector was employed to produce
the full-length VR1 with the eGFP tag. Rat VR1 with the short, 12-
amino acid e-tag (KGFSYFGEDLMP) was constructed in a vector,
peMTH, driven by the metallothionein promoter (17). Briefly, SalI and
MluI restriction endonuclease sites were incorporated into the VR1
PCR fragment amplified using the forward AGTAGTGTCGACGAACA-
ACGGGCTAGCTTAGACTCA and reverse TTGTTGACGCGTTTTCTC-
CCCTGGGACCATGGAATC primers, respectively. After cutting the
PCR fragment with these enzymes the size-separated cDNA insert was
ligated in peMTH at the compatible XhoI and MluI sites (17). The
chimeric constructs were verified by sequencing and transiently trans-
fected in COS7, HEK293, and NIH 3T3 cells employing the protocol
provided for the LipofectAMINE reagent (Life Technologies, Inc.). The
basal activity of the peMTH promoter was used in NIH 3T3 cells to
produce VR1e, yet prevent toxicity from long term, high level
expression.
Electrophysiology—For patch clamp studies, VR1eGFP-expressing
COS7 and HEK293 cells were voltage-clamped in Krebs buffer contain-
ing (in mM) NaCl (124), KCl (4.9), KH2PO4 (1.2), MgSO4 (2.4), CaCl2
(2.5), NaHCO3 (25.6), and glucose (10), using an Axopatch 200B ampli-
fier (Axon Instruments, Foster City, CA). Recordings were carried out
with patch electrodes (2–10 MV) filled with 10 mM HEPES buffer (pH
7.4) containing (in mM) CsCl (120), tetraethylammonium chloride (20),
CaCl2 (1), MgCl2 (2), EGTA (10), ATP (4), and GTP (0.5).
Determination of Ca21 Uptake—Cells were transfected at 80% con-
fluence in 75-cm2 T-flasks with 20 mg of VR1eGFP or VR1e plasmids.
After 48 h, 5 3 104 cells were detached from the plastic surface by
serum-free DMEM containing 1 mM EDTA and then washed two times
and resuspended in medium without EDTA. Cell suspensions were
incubated in serum-free DMEM containing 1 mCi/ml 45Ca21 and ligands
as indicated for 15 min at 35 °C in 96-well filtration plates (Multi-
Screen-DV, Millipore, Marlborough, MA). Ca21 uptake was terminated
on ice, and samples were processed and analyzed as described (18).
[3H]RTX Binding—48 h after transfection in 75-cm2 T-flasks, cells
were detached from the plastic surface by serum-free DMEM containing
1 mM EDTA and then washed and resuspended in 10 mM HEPES (pH
7.4) buffer, containing (in mM) KCl (5), NaCl (5.8), MgCl2 (2), CaCl2
(0.75), glucose (12), and sucrose (137). Intact cells were incubated (105/
well) in a filtration plate with 200 pM [3H]RTX for 60 min at 37 °C and
then processed as described earlier (5). Data were analyzed by computer
fit to the Hill equation as noted previously (18, 19).
Fluorescent Confocal Microscopy—COS7, NIH 3T3, and HEK293
cells were seeded on 25-mm coverslips and transfected with 1 mg each
of the plasmid constructs, cultured for 24 h post-transfection at 35 °C,
then mounted in a 1-ml chamber and examined with a MRC-1024
Bio-Rad confocal microscope. To study the two- and three-dimensional
distribution of fluorescent chimeric proteins, each x-y plane was
scanned over 1 s and at 0.2-mm increments in the z axis mode. To label
different subcellular compartments of live cells fluorescently, the ER
marker eGFP-KDEL (CLONTECH) was transiently transfected in
COS7 and NIH 3T3 cells. To label mitochondria, MitoTracker (Molec-
ular Probes) dye was incubated for 30 min at a 250 nM concentration;
the cells were then washed with Hanks’ balanced salt solution supple-
mented with 1 mM CaCl2 and 0.8 mM MgCl2, buffered with 15 mM
HEPES (pH 7.4) (HBSSH).
[Ca21]i Microfluorometry—For determination of [Ca
21]i, cells were
cultured in glass bottom dishes (MatTek Corp., Ashland, MA) and then
transfected with 2 mg of VR1eGFP plasmid. After 24 h in culture, cells
were loaded with Fura 2/AM (Molecular Probes, Eugene, OR) for 30 min
at 37 °C. Single cells expressing the VR1eGFP construct were identified
by eGFP fluorescence and were selected based on visual inspection of
fluorescence intensity. In all experiments, cells exhibiting intermediate
fluorescence in comparison to other cells in the same dish were picked
for analysis. To determine the [Ca21]i, the excitation ratio of Fura-2 at
340 and 380 nm was recorded photometrically in Krebs’ buffer at a
10-Hz sampling rate and integrated over 0.5 s, as described previously
(20). [Ca21]i was calculated using the ratio based equation (21).
Ratiometric Imaging of [Ca21]i Employing Confocal Microscopy—
Cells cultured on poly-D-lysine-coated coverslips were pre-loaded with 5
mM Indo-1 AM dye. After incubation for 30 min at 34 °C, the cells were
washed three times in HBSSH to remove excess dye and examined
under the confocal microscope. To record in “zero” extracellular Ca21
cells were washed four times (5 min each) in HBSSH containing no
CaCl2 and 1 mM EGTA and imaged in the same medium. Groups of cells
expressing VR1eGFP or small size neurons were selected under the
microscope. To quantitate the fluorescence ratio, perikarya of the cells
were marked with the graphic tools of the LaserSharp software in the
field of a 3 40 objective of the Bio-Rad confocal system. Ratiometric
imaging was performed at 10-s intervals with an UV laser, and the ratio
of fluorescence intensity emitted at 405 and 485 was calculated.
DRG Culture—DRG neuron-enriched cultures were prepared from
embryonic rats (E16). Briefly, embryos were removed from the uterus
and placed in Petri dishes containing Lebowitz medium (Life Technol-
ogies, Inc.). The cords were dissected, and the DRGs were stripped off
with the meninges. Cells were digested in 0.125% trypsin at 37 °C for 20
min. For plating, dissociated cells were changed into minimal essential
medium containing 5% horse serum and 50 ng/ml nerve growth factor
(NGF). Cells were seeded on 25-mm glass coverslips or on multiwell
plates. Surfaces were coated with poly-D-lysine and laminin. DRG cul-
tures were maintained in DMEM containing 20 mM HEPES, 7.5% fetal
bovine serum, 7.5% horse serum, 5 mg/ml uridine supplemented with 2
mg/ml FUDR to inhibit cell division and 50 ng/ml NGF to promote
neuronal survival and differentiation. Cultures were selected in this
medium for 1 week, at which point well differentiated neurons and
nondividing cells dominated the population. Primary DRG cultures in
this stage were used in confocal microscopy.
Western Blotting—Total protein extracts were prepared in denatur-
ing SDS buffer and analyzed for immunoreactivity by Western blotting
similar to that described by us previously (17). VR1-specific antibody
was raised in rabbits employing the N-terminal MEQRASLDSEES-
ESPPQE peptide of rat VR1 conjugated to keyhole limpet hemocyanin
as immunogen. Immune sera were affinity purified against the peptide
used for immobilization. The specific antibody fraction eluted from the
affinity column was diluted 1000-fold for further characterization in
Western blot and immunocytochemistry experiments. This antibody
fraction recognizes the native rat VR1, as illustrated in Fig. 11, and the
chimeric VR1eGFP and VR1e (data not shown). Stripping of nitrocellu-
lose blotting filters (Bio-Rad) was carried out in 200 ml of 50 mM
Tris-HCl buffer (pH 7.5) containing 2% SDS and 0.1 b-mercaptoethanol
at 65 °C for 1 h. Stripped blots were reanalyzed for tagged fusion
proteins either with the GFP (CLONTECH) or the ePKC-specific anti-
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bodies (Life Technologies, Inc.), prepared in rabbits. To assess equal
loading, filters were re-probed with a rat cytochrome c-specific mono-
clonal antibody (6H2.B4) as suggested by the manufacturer (Transduc-
tion Laboratories). Antibodies for Western blotting were used at a
1:1000 dilution. To visualize the interaction with the primary antibod-
ies, enhanced chemiluminescence technology was employed according
to the protocol provided by the manufacturer (New England Biolabs).
RESULTS
VR1e and VR1eGFP plasmid constructs were expressed in
COS7, HEK293, and NIH 3T3 cells by transient transfection.
Western blot analysis with polyclonal eGFP and e-tag-specific
antibodies demonstrated that the VR1eGFP and VR1e chimeric
proteins expressed in HEK293 and NIH 3T3 cells were of the
appropriate sizes, 120 and 93 kDa, respectively (Fig. 1, 1st and
3rd lanes). No tag-related immunoreactivity was found in the
nontransfected host cells (Fig. 1, 2nd and 4th lanes). Repeated
Western analyses with GFP- and e-tag-specific antibodies
showed no proteolytic cleavage of the VR1 chimeric proteins
(data not shown). These transiently transfected plasmid con-
structs expressed proteins that exhibited identical molecular
weights after the tag-specific antibodies were removed and the
blots re-probed with the N-terminal specific VR1 antibody
(data not shown).
To study the electrophysiological properties of C-terminally
eGFP-tagged VR1, plasmid constructs producing VR1eGFP
and eGFP as a control were transiently expressed in HEK293
cells. Green fluorescent cells of medium fluorescence intensity
were voltage-clamped, and the holding potential was adjusted
to 260 mV. Capsaicin (10 mM) induced a large inward current
(Fig. 2a). Similar currents were also evoked by administration
of 125 pM RTX to the cells; however, the currents rapidly
desensitized to repeated applications (n 5 6) (data not shown).
Capsaicin was noted to be less effective at inducing desensiti-
zation than RTX; therefore, CAP was used in experiments that
required repeated application of vanilloid ligands (e.g. Fig. 2).
As expected for a functional recombinant, the VR1eGFP-medi-
ated current was attenuated by coincubation of an antagonist,
10 mM capsazepine (CPZ). The current versus voltage relation-
ship demonstrated that the VR1eGFP-mediated current was
not particularly voltage-sensitive. The reversal potential was
near 0 mV, suggesting mixed cation selectivity for the channel
(data not shown). Cells transfected with eGFP did not demon-
strate currents when exposed to either CAP or RTX (Fig. 2b
and data not shown). Likewise, nontransfected HEK293 cells
did not demonstrate RTX-evoked currents. Overall, the electro-
physiological properties of the eGFP-tagged VR1 were very
similar to those described for nontagged VR1 (9).
In accordance with the electrophysiological data, exposure to
RTX induced Ca21 uptake in VR1eGFP-expressing HEK293
and COS7 cells. This ligand-induced Ca21 influx (Fig. 3a) fur-
ther confirms the presence of VR1eGFP at the plasma mem-
brane. RTX induced 45Ca21 uptake with an ED50 5 100 6 50
pM (n 5 3) whereas that for CAP was 0.5 6 0.15 mM (data not
shown). Similar results were obtained for VR1 tagged with the
12-amino acid e-epitope in place of the eGFP tag. This indicates
that a C-terminal tag, per se, does not significantly change
Ca21 uptake parameters. In addition, RTX-induced 45Ca21 up-
take was completely blocked by 10 mM CPZ in VR1eGFP- (Fig.
3a) and VR1e2expressing cells (not shown).
The curves in Fig. 3b demonstrate the quantitative charac-
teristics of [3H]RTX binding to eGFP-tagged and e-tagged VR1
expressed in COS7 cells. Both tagged recombinants exhibited a
high affinity, dose-dependent interaction (Kd ; 150 6 10 pM,
n 5 6) and cooperativity among the receptors (Hill coefficient 5
1.5–2). [3H]RTX binding was almost completely inhibited by
coincubation of 10 mM CPZ. No significant [3H]RTX binding was
FIG. 1. a, schematic representation of C-terminally tagged VR1. b,
Western blot analysis of the chimeric proteins. To generate VR1eGFP
and VR1e, the stop codon of the wild-type VR1 was deleted and the
C-terminal domain extended with the cDNA coding for the enhanced
green fluorescent protein or the e-tag as described under “Experimental
Procedures.” The intracellular ankyrin repeats, the enhanced green
fluorescent protein-, and e-epitope-tagged chimera proteins are abbre-
viated as A, VR1eGFP, and VR1e, respectively. b, VR1eGFP and VR1e
plasmids were transfected in HEK293 and NIH 3T3 cells, respectively.
After 48 h 35 mg of total protein extract, prepared in SDS sample buffer,
was analyzed for the eGFP (lanes 1 and 2) and e-tag immunoreactivities
(lanes 3 and 4) by Western blotting, employing eGFP and e-tag specific
antibodies, respectively. Enhanced chemiluminescence was employed
to visualize the interaction with the primary antibodies, as described
under “Experimental Procedures.” The molecular weight was calcu-
lated from the mobility of the immunoreactive protein band compared
with protein standards.
FIG. 2. Vanilloid currents in transiently transfected HEK293
cells. HEK293 cells were cultured on laminin-coated coverslips in
6-well plates and transfected with VR1eGFP (a) or eGFP plasmids (b).
After 48 h, cells expressing the fluorescent proteins were selected for
voltage clamp assays. The holding potential for all of the cells was 260
mV. a, 10 mM CAP was bath-perfused for 30 s for the first application
and 1 min for subsequent applications to induce currents in VR1eGFP-
expressing cells. The first treatment with CAP was shortened to reduce
the amount of receptor desensitization. The antagonist 10 mM CPZ
attenuated the capsaicin-induced current (n 5 4 cells). The drugs were
washed out of the bath for 10 min between applications. b, capsaicin (10
mM) (n 5 4 cells) did not evoke currents in eGFP transfected HEK293
cells. Drug application was 1 min.
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detected in cells transfected with the plasmid expressing only
eGFP (Fig. 3b).
Confocal fluorescence microscopy was employed to analyze
the intracellular distribution of VR1eGFP. Optical sections
taken at the plane of cell attachment to the glass surface show
VR1eGFP fluorescence in the plasma membrane, where mi-
crovilli were labeled (Fig. 4a, VR1 accumulation also is present
at the focal points in this plane, not seen with fluorescent
markers of ER). Optical sections taken through the middle of
the cell nucleus, disclosed VR1eGFP in intracellular structures
consistent with the ER (Fig. 4, b versus d). To confirm ER
localization, cells were transfected with an eGFP that was
C-terminally tagged with the ER retention signal (i.e. the
KDEL motif, Fig. 4b). Visualization of the transiently ex-
pressed eGFP-KDEL chimera protein in COS7 cells verified
that VR1eGFP indeed stained the same ER compartment
within the cytoplasm and around the nucleus (Fig. 4, b versus
d). Furthermore, the same ER colocalization result was ob-
tained when VR1eGFP-expressing cells were costained with
the ER-tracker vital dye (Molecular Probes) (not shown). Fig. 4
illustrates localization of VR1 in COS7 cells but a similar ER
localization was seen in HEK293 and NIH 3T3 cells, indicating
that it is not a cell type-specific anomaly. ER localization was
observed over a range of transfection efficiencies, and the dis-
tribution between the plasma membrane and ER was similar in
cells expressing VR1eGFP at different levels (not shown). The
proportionality between plasma membrane and ER also was
maintained in a cell line stably expressing relatively lower
levels of VR1e from the noninduced MTH promoter. These
data, as well as results from immunocytochemical staining of
fixed DRG neurons, which show a high density of staining
throughout the neuronal cytoplasm (10), suggest the distribu-
tion is not simply due to overexpression. Dual wavelength
imaging studies demonstrated that the intracellular compart-
ment containing VR1eGFP (green) was distinct from the fila-
mentous mitochondria (red), which were labeled by the red
MitoTracker dye and are generally much thicker than the ER
(Fig. 4f).
Previously it was noted that addition of ionomycin to cells
induces intracellular membrane fragmentation due to perme-
abilization of the plasma membrane to cations (22). This was
verified in baseline control studies using the eGFP-KDEL-
expressing plasmid, which showed that ionomycin treatment
induced membrane fragmentation of the ER (Fig. 4, b versus c).
This fragmentation was identical to what occurred with
VR1eGFP-expressing cells upon exposure to 1 nM RTX. In these
cells a 20-s exposure induced fragmentation of the ER (Fig. 4,
d and e) and, simultaneously, a rounding up of the filamentous
mitochondria (Fig. 4, f versus g). Testing of a second vanilloid
ligand, CAP (1 mM), also demonstrated membrane fragmenta-
tion with similar dynamics as noted with RTX (not shown).
With the appropriate sets of fluorescence filters, we observed
no mixing between the VR1eGFP vesicles (green) and the mi-
tochondrial membranes (red) (data not shown). In cells express-
ing only eGFP, the structure of the mitochondria and ER did
not change upon exposure to vanilloids, indicating the depend-
ence for these effects on the presence of the VR1 receptor. Thus,
within the first few seconds after vanilloid exposure, coincident
and structurally similar intracellular organelle remodeling oc-
curs for both the ER and the mitochondria.
The effect of RTX on cytosolic Ca21 was studied by microflu-
orometry in transfected cells loaded with the Ca21-monitoring
dye, Fura-2 AM. The resting [Ca21]i was similar (;50 nM) in
COS7 cells transfected with either VR1eGFP or eGFP plas-
mids. Addition of 1 nM RTX induced a rapid (within 10 s)
elevation of [Ca21]i in VR1eGFP-expressing cells which peaked
at 500 nM at ;1 min (n 5 3) and, consistent with the concurrent
ER and mitochondrial damage (Fig. 4, e and g), did not return
to resting levels (Fig. 5a). In the absence of external Ca21, the
RTX-induced increase in [Ca21]i was temporally delayed from
#10 s to ;1 min (see Figs. 7 and 8). No increase in [Ca21]i was
observed in cells expressing only eGFP (n 5 3) (not shown).
The preceding experiments focused on events occurring
within the first few seconds following exposure to VR1 agonists.
To extend the time of cellular observation, serial 1-s confocal
microscopy scans were performed at 1-min intervals on live
VR1eGFP-expressing cells. In these experiments the early
events occurred as described (e.g. transmembrane Ca21 flux,
intracellular remodeling, within 30 s in 13 out of 15 cells).
Within 3 min after RTX administration, the nuclear membrane
was outlined with VR1eGFP fluorescence, and ER membrane
vesicles were observed around the nucleus (Fig. 5c). Then,
progressively growing blebs were noted in the nuclear mem-
brane (2 out of 10 at 5 min and 9 out of 10 cells at 10 min). In
the cell shown, the membrane degradation concluded with
bursting of the plasma membrane at 43 min (Fig. 5c). Other
FIG. 3. a, RTX-induced Ca21-ionophore activity of the VR1eGFP
(squares) and VR1e (diamonds). HEK293 cells were transfected for 48 h
with the plasmid constructs and then 45Ca21-uptake was induced with
the indicated concentrations of RTX. The 45Ca21 uptake experiments
were carried out as described under “Experimental Procedures.” The
results were analyzed by fitting the Hill equation to the data points.
The effects of 10 mM CPZ cotreatment with increasing concentrations of
RTX on 45Ca21 uptake were determined with VR1eGFP-transfected
cells (open circles). b, demonstration of vanilloid binding activity of the
VR1eGFP (squares) and VR1e (diamonds) chimeric constructs ex-
pressed in COS7 cells. [3H]RTX binding experiments were carried out
48 h following the transfection as described under “Experimental Pro-
cedures.” The results were analyzed by fitting the Hill equation to the
data points. The effect of 10 mM CPZ on the binding of 0.5 nM [3H]RTX
is indicated by the filled diamond (VR1e) and the filled square
(VR1eGFP), respectively. Background binding was determined in cells
transfected with a control plasmid (eGFP, filled circles). Results are
from a single experiment carried out with triplicate determinations.
Two additional experiments yielded similar results.
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cells displayed similar nuclear changes and cell disruption
within 1–2 h (3 out of 5 within 1 h and 5 out of 5 monitored for
2 h in one experiment). Lower doses of RTX (#0.1 nM) evoked
slower nuclear membrane fragmentation but eventually re-
sulted in cell lysis (4 out of 4 cells within 3 h). The effects were
not due to the repetitive scanning, since single scans of trans-
fected cells performed at 30 min after RTX administration also
revealed (8 out of 8) identical effects of RTX on intracellular
membrane structures.
Fig. 6 summarizes quantitatively the fluorescence scanning
confocal microscopy data collected in repeated experiments. ER
fragmentation was noted in 16 cells within 6 s of adding 1 nM
RTX; vesiculation was completed within 1 min in each cell
monitored (scans were done every 6 s, n 5 30). ER vesiculation
directly corresponded to the time course determined for RTX-
induced [Ca21]i accumulation (Fig. 5a). The first nuclear bleb
appeared 2 min after RTX treatment (2 out of 30) and then each
observed cell (n 5 30) showed at least 1 bleb by 10 min. Cell
lysis started as early as 10 min after RTX addition (1 out of 30
cells) and was complete within 2 h (30 out of 30 cells).
To explore potential activity of the ER-localized VR1, COS7
cells expressing VR1eGFP were treated with 1 nM RTX in the
absence of extracellular Ca21. VR1eGFP-expressing cells, pre-
washed extensively in 1 mM EGTA, showed vesiculation of the
ER and disruption of mitochondria similar to that determined
in the presence of 1 mM extracellular Ca21 (Figs. 4 and 5).
However, the time required for these changes was much longer,
on the order of minutes rather than seconds. The first obvious
signs of ER fragmentation and round up of mitochondria were
noted at ;3 min after 1 nM RTX addition (5 out of 5). Nontrans-
fected cells (n 5 2) in the same microscopic field showed an
intact mitochondrial structure as determined by MitoTracker
fluorescence, indicating that the vanilloid effects on the intra-
cellular membranes were specific to those cells expressing
VR1eGFP (Fig. 7). If the extracellular Ca21 concentration was
adjusted back to 1 mM in the presence of 1 nM RTX, it triggered
an abrupt ER fragmentation (within 1–3 s in 5 out of 5 cells)
demonstrating the pivotal function of Ca21 in this process (data
not shown). These data suggest that the ER-localized VR1
mobilizes calcium from the ER but that [Ca21]i accumulation
occurred more slowly or that the amounts were such that the
[Ca21]i accumulation was buffered and more time was required
to reach toxic cytoplasmic concentrations.
The quantitative aspects of calcium release from internal
stores are presented in Fig. 8, which examines both DRG neu-
rons, and transiently transfected COS7 cells. In recording me-
dium containing zero extracellular Ca21, ratio imaging of
VR1eGFP-positive COS7 cells (exhibiting medium or low green
fluorescence intensity, Fig. 8a) or small size DRG cells (Fig. 8b)
demonstrated dramatic increases in the 405/485 ratio after
administration of RTX. Control nontransfected COS7 cells did
not show any change in the 405/485 ratio when exposed to RTX.
As noted above, the increase in [Ca21]i in the zero extracellular
Ca21 conditions was temporally delayed, requiring ;1 min. By
comparison, cells exposed to RTX in the presence of 1 mM
extracellular Ca21 exhibit an increase within #10 s. The ;45–
50-s delay also occurred in small size DRG neurons (Fig. 8b).
The RTX-induced ratio increase in cells expressing VR1eGFP,
and small size DRG neurons indicates Ca21 release from inter-
nal stores and [Ca21]i accumulation in the cytosol. These ex-
FIG. 4. Early dynamics of VR1 activation imaged in live cells. To determine the in vivo cellular location of the fluorescently labeled
VR1eGFP (a, d, and e), studies with eGFP-KDEL (b and c) and MitoTracker vital dyes (f and g) were carried out 24 h after transfection in COS7
cells employing laser confocal microscopy. In optical sections close to the glass surface VR1eGFP was localized in microvilli at the plasma
membrane in transiently transfected live COS7 cells (a). The bright spots are the focal points at the basal membrane glass interface. Arrowheads
show the extrusion of VR1eGFP-labeled plasma membrane microspikes at the edge of the cell. In median optical sections, at level of the cell
nucleus, VR1eGFPs are depicted in an intracellular membrane network similar to ER (d). Similarities in eGFP-KDEL and VR1eGFP in this optical
section verify that VR1 indeed can localize to the ER compartment. To study the effects of ionomycin (4-bromo-A23187) on intracellular
membranes, the same cell was imaged by the expressed ER marker, eGFP-KDEL (b and c) before and 10 s after addition of 4 mM ionophore. The
effects of RTX treatment were depicted with the VR1eGFP (d and e) and MitoTracker (f and g)-derived fluorescence before and 20 s after addition
of 1 nM RTX. The membrane permeabilization to cation by ionomycin or activation of VR1 by RTX resulted in a similar ER vesiculation (c and e),
indicative of similar mechanism and vesiculation of the mitochondria (g). Bar, 5 mm.
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periments suggest that the intracellular VR1 is functional and
that RTX, a lipid-soluble agonist of VR1, can indeed act as an
agonist at these intracellular sites.
To verify that the rapid intracellular membrane changes
observed in heterologous cells expressing VR1 also occurred in
small-size DRG neurons, experiments were carried out on pri-
mary cultures from DRG (Fig. 9). Cultures were preincubated
with the MitoTracker dye and then exposed to 1 nM RTX. Small
size neurons were selected and monitored by confocal micros-
copy employing 1-s scans every 20 s before and after treatment
with vanilloids. Neurons in this size range were previously
determined to be VR1-positive with an antibody raised against
the N-terminal 18 amino acids of VR1 (data not shown). The
MitoTracker dye revealed normal, slightly elongated mitochon-
dria in untreated small size DRG neurons (Fig. 9a). Treatment
with RTX induced the mitochondria to fragment within 20 s
(Fig. 9b), similar to the kinetics observed in COS7 cells ectopi-
cally expressing VR1eGFP (Fig. 4, d versus e). RTX at 1 nM
concentration was without effect on mitochondria localized in
the glial cell population (Fig. 9c) or in nearby large neurons
within the field of view (data not shown).
The above experiments demonstrated that vanilloids rapidly
target the ER and mitochondria at the cell body in small size
DRG neurons expressing VR1, producing effects within sec-
onds. To address the effects on DRG neurons of longer exposure
to RTX, DRG cultures were subjected to dual wavelength flu-
orescent imaging. Cultures were loaded with Indo-1 AM and
then incubated in HBSSH containing 1 mM CaCl2. Propidium
iodide (PI) was added to the imaging chamber just before the
cultures were examined with confocal microscopy. In repeated
experiments, specific neurons in the field of view demonstrated
instant increases in [Ca21]i (within seconds) upon administra-
tion of 25 nM RTX. Neurons exhibiting the RTX-induced in-
crease in [Ca21]i started to accumulate PI in the nucleus ;40
min after addition of RTX; a time that coincides with loss of
plasma membrane integrity in VR1eGFP-expressing COS7
cells exposed to RTX (Figs. 5 and 6). In the same microscopic
field there were neurons that neither responded to RTX with an
elevation in [Ca21]i nor accumulated PI even after 2 h of
exposure (Fig. 10). This result is consistent with the idea that
these neurons do not express VR1 and reinforces the cellular
and molecular specificity of vanilloid actions on DRG neurons.
Repeated time course observations with DRG cultures indi-
cated similar dynamics for DRG neuronal death as described
for transiently (see Fig. 6) or stably transfected NIH 3T3 cells
(not shown) expressing recombinant VR1.
Elevated [Ca21]i can induce cytotoxicity within minutes to
hours in VR1-expressing cells or specific DRG neurons, as
demonstrated in previous experiments. This suggests that va-
nilloid application to the perikarya may be an effective means
for specific deletion of nociceptive neurons. To study this phe-
nomenon, 1-week-old DRG cultures from rats were treated
with 50 mM olvanil (OLV, a long chain fatty acid modified
synthetic vanilloid) or 25 nM RTX for 48 h. From these cultures,
total protein extracts were prepared in denaturing SDS sample
buffer (Fig. 11). Western blot of VR1 protein and densitometry
of films after enhanced chemiluminescence visualization re-
vealed that olvanil treatment almost completely eliminated
(99% decrease) neurons expressing VR1 from the culture. RTX,
employed at a concentration 2,000-fold less than OLV, elimi-
nated ;80% of the neurons expressing VR1. Other cell types
present in the DRG culture were not affected after 48 h of
FIG. 5. Ca21 microfluorometry and cell death. For microfluorom-
etry of intracellular free Ca21 (a), VR1eGFP-expressing COS7 cells
were cultured and transfected in glass bottom dishes and then loaded
with the Ca21 indicator dye Fura2/AM for 30 min. Single VR1eGFP-
transfected cells were first identified by their green fluorescence. Once
the cell was in focus, microfluorometric determinations of [Ca21]i were
carried out for 60 s and then 1 nM RTX was perfused for 1 min as
indicated. To reduce the noise of single cell recordings 5 consecutive
data points were averaged. b, live cell imagings of short term membrane
remodeling due to RTX treatment were carried out in COS7 cells
expressing VR1eGFP. RTX (1 nM) was added 24 h after transient
transfection, and selected cells were scanned for 1 s at 30-s intervals as
indicated. Remodeling of the ER started within 30 s, coincident with the
rise in [Ca21]i. c, for long term in vivo monitoring of RTX effects, cells
were continuously perfused in an imaging chamber for 1 h. Following 3
min of perfusion, a representative VR1eGFP-expressing cell was se-
lected and imaged by 1-s laser scanning at 1-min intervals for 45 min.
Nuclear blebs became apparent within 3 min, and cell lysis occurred 43
min after the RTX was administered. Other cells displayed similar loss
of integrity, and the data are summarized graphically in Fig. 6.
FIG. 6. Quantitative analysis of membrane changes due to 1 nM
RTX treatment depicted by confocal microscopy. Imaging data
were derived from 30 independent transient transfection experiments
carried out with VR1eGFP-expressing COS7 cells; cells exhibiting an
intermediate level of fluorescence were chosen for imaging. Symbols at
each step of the three graphs represent the percentage of cells from the
30 cells imaged responding within the time frames indicated (e.g. the
1st diamond indicates that 16 cells responded with ER vesiculation
within 1–6 s). The dotted line superimposed on the graphs represents
the smoothed accumulation curve of [Ca21]i from Fig. 5. The entire
tubular ER network, decorated with VR1eGFP previous to 1 nM RTX
treatment, changed into circular ER vesicles (diamonds); the first nu-
clear blebs were observed at ;2 min (circles). Loss of cell membrane
integrity was seen in 1 cell out of 30 at 10 min and progressed until lysis
of all 30 cells was complete at ;2 h (squares).
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treatment with OLV or RTX, as assessed by re-probing the
same Western blots with an antibody recognizing the common
tissue protein cytochrome c (Fig. 11).
DISCUSSION
The present paper investigates the early cellular dynamics of
vanilloid-triggered events through in vivo expression of fluo-
rescent- and epitope-tagged recombinants of rat VR1. Exten-
sion of the C terminus with the 27-kDa eGFP did not compro-
mise the electrophysiological function of VR1 upon expression
in heterologous cell systems and tagging with either eGFP or a
short 12-amino acid e-epitope did not affect vanilloid-induced
ionophore function as assessed by 45Ca21 uptake. The ultrapo-
tent vanilloid, RTX, binds with nanomolar affinity to both
VR1eGFP and VR1e. The binding and 45Ca21 uptake parame-
ters are similar to those reported either for the nonchimeric
VR1 or for rat DRG primary cultures (3, 4, 14, 23–26). The
electrophysiology of VR1eGFP-expressing cells showed that va-
nilloids rapidly induced an inward current flow that was
blocked by CPZ, as described for wild-type VR1 (9). Vanilloid-
induced 45Ca21 uptake and [3H]RTX binding were also inhib-
ited by CPZ, further supporting the specific interaction of va-
nilloids with the tagged VR1 variants. VR1eGFP and VR1e
mimic the wild-type receptor and are thus useful reporters with
which to study the dynamics of VR1 activation by vanilloids,
other modulators, and physical stimuli.
In addition to localization at the plasma membrane,
VR1eGFP was demonstrated in the ER by colocalization with
the fluorescent ER-tracker dye in live COS7, HEK293, and
NIH 3T3 cells, as determined using high resolution confocal
microscopy. One of the benefits of this localization and fluores-
cent tagging was the elucidation of the abrupt ER fragmenta-
tion due to agonist treatment. Addition of RTX to VR1-express-
ing cells induced ;10-fold accumulation of [Ca21]i. This
coincided with the rapid transformation of the normal lattice-
like ER membrane structure into rounded vesicles, the earliest
hallmark of Ca21 cytotoxicity observed in living cells so far
FIG. 7. Live COS7 cells expressing VR1eGFP are depicted after
extensive washing in 1 mM EGTA and incubation in calcium-free
media. a, NT stands for nontransfected cells that cannot be seen in a
but visualized by the red fluorescent MitoTracker dye b. The cells from
the same microscopic field were then treated with 1 nM RTX in the
absence of Ca21 and monitored with the green and red channels. The
slow laser scanning (3 times for 1 s) and Kalman filtering option of the
confocal microscope were employed in each minute to take pictures on
both channels. At 3 min, pronounced reorganization of the ER and
mitochondrial membranes was noted (c and d), which progressed to
fragmentation of the ER and rounding up of the mitochondria at 10 min
(e and f) in VR1eGFP-expressing cells. Mitochondria in nontransfected
cells did not show these intracellular changes due to RTX treatment (b
versus d and f). For the repeated time series, cells were stained with 250
nM MitoTracker dye 30 min before confocal microscopy. VR1eGFP-
transfected cells were selected randomly and monitored up to 30 min
after the RTX addition. Similar results were obtained in three addi-
tional independent experiments.
FIG. 8. RTX-induced mobilization of Ca21 from internal
sources in the absence of extracellular Ca21. DRG and VR1eGFP-
expressing cultures were prepared as described under “Experimental
Procedures.” For ratiometric confocal imaging, DRG neurons and
VR1eGFP-expressing cells were pre-loaded with 5 mM Indo-1 AM dye.
After incubation for 30 min at 34 °C the cells were washed three times
in HBSSH containing 1 mM EGTA to remove extracellular Ca21 and
excess dye. Group of transiently transfected cells expressing VR1eGFP
(a) and primary cultures of DRG neurons (b) were selected and then
perikarya marked for ratiometric imaging in the field of a 40 3 objec-
tive. RTX was added to make a 1 nM final concentration in the medium.
The ratio of emitted fluorescence intensity at 405 and 485 was calcu-
lated from images taken at 10-s intervals. a, data shown are from a field
of view containing three VR1eGFP-transfected and three nontrans-
fected COS7 cells. b, primary sensory neuronal showed similar mobili-
zation of Ca21 from intracellular stores. The graph is from three neu-
rons exhibiting a Ca21 response and two neurons that did not show a
change in fluorescence ratio. Data were replicated in three other cul-
tures, which also showed Ca21 mobilization from intracellular sources,
as illustrated here.
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(Fig. 6). Calcium-induced ER vesiculation occurred throughout
the cytoplasm (i.e. the z-stack of confocal acquisition), similar
to that described previously for ionomycin (22). This type of
membrane rearrangement (Figs. 4, 5, and 7) is clearly distinct
from the agonist-mediated endocytosis, which can occur with
nonion channel transmembrane receptors. In addition to the
ER, the live cell imaging experiments revealed other mem-
brane compartments that reacted to the vanilloid-induced ele-
vated [Ca21]i. These include the following: (i) shedding of the
plasma membrane; (ii) intracellular fragmentation of mito-
chondria; and later (iii) blebbing of the nuclear envelope; (iv)
accumulation of propidium iodide in the cell nucleus; and (v)
rupture of the plasma membrane (Figs. 4, 5, 9, and 10).
The intracellular location of VR1 was separable from the
mitochondrial compartment as assessed concurrently with the
red MitoTracker dye (Figs. 4 and 7). Although spatially dis-
tinct, both the ER and mitochondria fragmented in seconds
upon the large increase in [Ca21]i through VR1 (Figs. 4, 5, 9,
and 10). The staining of the mitochondrial compartment with
the MitoTracker vital dye provided a surrogate end point to
extend our findings in transiently transfected cells to DRG
neurons in primary culture where specific small sized neurons
showed the same immediate early changes in mitochondrial
structure when exposed to vanilloids (Figs. 4, 7 versus 9).
However, the perikarya of the responding neurons are spheroid
rather than flat and extended, and a much smaller volume is
available for confocal microscopy due to the high nucleus/cy-
tosol ratio. Thus, in contrast to the flattened COS7 cells, ge-
ometry and size make nociceptive neurons less favorable sub-
jects for live cell imaging of elongated organelles such as the
mitochondria and the ER. As expected for the restricted cellu-
lar expression of VR1 in the DRG (9), RTX did not affect the
mitochondria of adjacent large neurons or glia, imaged at the
same time (Fig. 9).
The potential role of ER-localized VR1 is not yet clear, and
we continue to investigate it. Our studies in calcium-free media
show that a similar vanilloid-induced, VR1-specific remodeling
of ER can occur with Ca21 mobilized from intracellular sources,
although with a much slower time course. Orientation or fold-
ing of VR1 in the ER may be factors, but the lag period in
heterologous systems and DRG neurons (Figs. 7 and 8) also
suggests buffering mechanisms are present (i.e. mitochondrial
Ca21 uptake (27)) or that multiple steps are required for acti-
vation of ER-localized ion channels (22, 28). The delay is not
due to lack of membrane penetration of vanilloids, which are
highly lipid-soluble. In fact, the water-soluble CAP analogue
DA-5018 can only bind to VR1 when applied intracellularly,
implying that vanilloids first must traverse the plasma mem-
brane for activation of VR1 Ca21 signaling (29). Other investi-
FIG. 9. Live confocal imaging of MitoTracker dye stained,
small size DRG neurons. Cultures were prepared from E16 rats and
maintained on 25-mm laminin-coated glass coverslips in DMEM con-
taining NGF and FUDR for 1 week before confocal microscopy as
described under “Experimental Procedures.” After incubation for 30
min in 250 nM MitoTracker dye, cells were washed two times and
examined in HBSSH containing 1 mM Ca21 (a) and then RTX was added
to make a 1 nM final concentration. Cells are depicted 20 s after the
treatment (b). Mitochondria of a glial cell are shown from the same
culture 10 min after the RTX treatment (c). In the spherical neuronal
perikarya, the otherwise elongated mitochondria are packed densely
(a), but the fragmentation due to RTX is evident (b), especially when
compared with well preserved mitochondria, depicted in the large, flat
glial cell from the same culture after vanilloid drug administration (c).
The glial cell shown is typical; none of the glia in the culture were
affected by RTX. Scale bar, 2 mm.
FIG. 10. Relationship between RTX-induced accumulation of
[Ca21]i and cell death in DRG neurons. Cells were examined by
confocal microscopy at 405 and 485 nm. Individual cells are numbered
in a and ratios of 405/485 of the numbered neurons are plotted in b.
Dissociated DRG neurons were seeded on poly-D-lysine pre-coated cov-
erslips. Cultures were loaded with the Indo-1 AM, 30 min before the
experiments, and then washed and changed into recording medium
containing 1 mM CaCl2. PI was added just before confocal microscopy
(40 3 objective). First, ratio imaging at 405 and 485 nm was carried out.
Frames taken on the 485 nm channel are shown, employing a geo-
graphic look-up table (a, 0 and 100 s). PI fluorescence was depicted on
the red channel at 2 h, as indicated. RTX (25 mM), added at 70 s, induced
an instant change in the 405/485 ratio as illustrated visually by the
denominator channel (a, 0 and 100 s), and plotted in b. In some neurons
(cell-1, -2, and -3) the red color shifted in the blue direction, indicative
of a steep elevation in [Ca21]i (within seconds). In other cells (cell-4 and
-5) little change in color (red) indicated a steady, low basal level of
[Ca21]i. The identical cells that reacted to RTX with an elevated [Ca
21]i
also accumulated PI in the nucleus (cell-1, -2, and -3), indicating plasma
membrane damage (a). Neurons resistant to RTX-induced elevation of
[Ca21]i excluded PI even after 2 h (cell-4 and -5). Similar results were
recorded in two additional DRG cultures.
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gations (30–32) have shown that removal of extracellular cal-
cium diminishes but does not eliminate physiological effects in
a variety of systems including vanilloid-evoked inward cur-
rents with repeated administration of vanilloids in cultured
DRG neurons. Furthermore, it was observed that capsaicin
stimulated release of substance P from C-fibers in the absence
of extracellular Ca21 (33). Here we positively identified a de-
layed but RTX-induced Ca21 release from intracellular stores
in zero extracellular Ca21, implying an important role of ER-
localized VR1 (Fig. 8). These observations, together with pre-
vious electrophysiological data (30, 31), indicate that, in addi-
tion to the plasma membrane exposed VR1, a novel, functional,
intracellular (i.e. ER) pool exists in DRG neurons. The results
are consistent with the interpretation that, in the ER, VR1
gates Ca21 stores which respond to vanilloids by releasing
Ca21 to the cytosol (Figs. 7–10).
Our data show that, as time progresses, the vanilloid-in-
duced elevation in cytosolic Ca21 produces an evolving cytotox-
icity. Within 10 min, progressive nuclear blebbing is seen
which coincides with PI incorporation in the nucleus, followed
by lysis of the plasma membrane and cell death in 1–2 h in both
VR1-expressing cells and DRG neurons. These more long term
events are shown as a series of single frames in Figs. 5 and 10;
however, upon replay of the frames from transfected cells or
DRG neurons as a video clip (not shown), the vanilloid-induced
PI accumulation in the cell nucleus and cell lysis highlights the
dramatic nature of the cell death. The selectivity is also appar-
ent since adjacent nontransfected or non-VR1-expressing cells
remain resistant to PI permeation (Fig. 10).
Double wavelength imaging of consecutive accumulation of
[Ca21]i and propidium iodide due to RTX treatment and West-
ern blot analysis of VR1 in primary DRG cultures all support
the selectivity of vanilloid-induced cell deletion. Western blot
data from DRG cultures (Fig. 11), together with images of cells
heterologously expressing VR1eGFP (Fig. 5) or of DRG neurons
(Fig. 10), indicate that RTX treatment first compromises the
function of cell organelles and then kills the cell. These data
argue against specific VR1 proteolysis or desensitization of
VR1 by limited endo- or exocytosis as mechanisms mediating
VR1 protein elimination from the primary cultures.
Several mechanisms can govern the intracellular remodeling
and cell death that occur upon exposure to vanilloids. The most
likely is rapid Ca21 toxicity following VR1 activation, which is
consistent with the data presented here from VR1-expressing
cells and DRG neurons (Figs. 4–11) and by others (9, 27).
Although the primary steps of Ca21 toxicity are similar to
apoptosis, including nuclear blebbing and PI staining of the
nucleus (34), chromatin fragmentation, apoptotic body forma-
tion, and caspase activation were not apparent within 24 h
(data not shown). Previous studies characterized only the ter-
minal phase of vanilloid-induced cellular changes in detail. The
longer term dynamics visualized with VR1eGFP in the present
study are consistent with those noted with end point observa-
tions in the DRG, including intracellular membrane fragmen-
tation, mitochondrial swelling, and nuclear envelope segmen-
tation (8, 34–36). By extension, these results are generalized to
a variety of ligand-operated Ca21 channels such as the excita-
tory amino acid N-methyl-D-aspartic acid receptor, which can
be activated by potent toxic ligands (37, 38).
The present data suggest a new potential therapeutic use of
vanilloids, which is the targeted removal of nociceptive primary
afferent neurons. Among the wide variety of VR1 agonists,
OLV may have several advantages for clinical application. It is
reported not to cause painful activation of the nociceptive af-
ferent ending and, therefore, may be less inflammatory than
other vanilloids (39). Our data also show that OLV is nontoxic
to cells devoid of VR1 up to 50 mM, yet this concentration almost
completely and specifically removes VR1-expressing cells in
DRG culture (Fig. 11). Clinical application of vanilloids could
be made regionally selective by the use of image-guided intra-
ganglionic or nerve root administration to trigger specifically
increases in [Ca21]i at the level of the neuronal perikarya in
sensory ganglia involved in a pathological pain state. Preclin-
ical data based on our experience with epidural RTX or capsa-
icin administered to adult rats (5, 40) suggest that loss of C
fibers via this approach would be an effective means for pain
control.
In summary, our data refine the early dynamics of Ca21
cytotoxicity in VR1-expressing cells. Fluorescent imaging in
live cells revealed that at least three vital organelles are im-
mediately damaged due to increased [Ca21]i conferred by the
agonist-activated VR1. One is the ER, which reacts with abrupt
fragmentation. The others are the mitochondria and cell nu-
cleus. These organelles are present in the cell body of sensory
neurons; therefore, disruption of their function equally can
contribute to desensitization and elimination of VR1-express-
ing cells (5). Our primary culture experiments suggest that
precise targeting of vanilloids to the perikarya in sensory gan-
glia can induce specific elimination of VR1-positive cells by
Ca21 cytotoxicity, characterized here in detail. A similar strat-
egy may have clinical utility in select conditions to remove
nociceptive neurons causing intractable pain in humans.
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